Edx Medical Group Final Earnings Report

Edx Medical Group EPS Results

• Actual EPS: -GBX 1.50
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Edx Medical Group Revenue Results

• Actual Revenue: N/A
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Edx Medical Group Announcement Details

• Quarter: Final
• Date: 9/3/2026
• Time: Before Market Opens
• Conference Call Date: N/A
• Conference Call Time: N/A

Edx Medical Group (LON:EDX) plc is a United Kingdom-based medical diagnostics company focused on developing and commercializing clinical tests intended to support the detection, diagnosis and management of disease. Its work is centered on molecular and genetic testing, with an emphasis on providing more personalized information to healthcare professionals and patients.

The company’s activities include the development of diagnostic and screening products for applications such as cancer and other significant health conditions. Its testing approach is designed to analyze biological and genetic information that may help inform clinical decisions, including disease assessment and treatment selection.

EDX Medical Group serves the healthcare and life sciences markets, primarily through its United Kingdom operations. The company is listed on the London Stock Exchange and is focused on advancing diagnostic technologies from development toward use in clinical settings.